Category:Xuecui Guo of Oyster Bay NY (US)

Xuecui Guo of Oyster Bay NY (US)

Executive Summary

Xuecui Guo of Oyster Bay NY (US) is an inventor who has filed 2 patents. Their primary areas of innovation include Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers} (2 patents), MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (2 patents), {General methods applicable to biologically active non-coding nucleic acids} (1 patents), and they have worked with companies such as MeiraGTx UK II Limited (2 patents). Their most frequent collaborators include (1 collaborations), (1 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• C12N15/115 (Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers}): 2 patents
• C12N2310/16 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• C12N15/111 ({General methods applicable to biologically active non-coding nucleic acids}): 1 patents
• C12N15/67 (General methods for enhancing the expression): 1 patents
• C12N2310/126 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/3519 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/531 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• A61K48/0008 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 1 patents
• A61K48/0066 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 1 patents
• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 1 patents
• C12N15/86 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2830/42 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents

Companies

List of Companies

• MeiraGTx UK II Limited: 2 patents

Collaborators

• Michael J. Volles of Cambridge MA (US) (1 collaborations)
• Olivier F. Danos of New York NY (US) (1 collaborations)